Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.980
-0.160 (-5.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.980
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Evotec SE Employees
Evotec SE had 4,467 employees as of December 31, 2025. The number of employees decreased by 273 or -5.76% compared to the previous year.
Employees
4,467
Change
-273
Growth
-5.76%
Revenue / Employee
$207,219
Profits / Employee
-$27,209
Market Cap
1.07B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | 4,198 | 626 | 17.53% |
| Sep 30, 2021 | 4,081 | 637 | 18.50% |
| Jun 30, 2021 | 3,914 | 636 | 19.40% |
| Mar 31, 2021 | 3,735 | 705 | 23.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Perrigo Company | 8,100 |
| Tilray Brands | 2,842 |
| Amphastar Pharmaceuticals | 1,976 |
| Alvotech | 1,279 |
| ANI Pharmaceuticals | 970 |
| Pacira BioSciences | 829 |
| Cronos Group | 610 |
| Collegium Pharmaceutical | 423 |
EVO News
- 4 days ago - Evotec Announces Chief Financial Officer Transition - Accesswire
- 13 days ago - Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer - Accesswire
- 21 days ago - Evotec vows to further engage with investor MAK, who demanded change - Reuters
- 21 days ago - Evotec Nominates Dieter Weinand as Supervisory Board Chairman - Accesswire
- 27 days ago - Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 - Accesswire
- 27 days ago - Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer - Accesswire
- 5 weeks ago - Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses - Accesswire
- 5 weeks ago - Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation - Accesswire